Research on relevance between mitochondrial ATP synthase and malignant tumor / 生物医学工程学杂志
Journal of Biomedical Engineering
;
(6): 714-717, 2014.
Artículo
en Chino
| WPRIM
| ID: wpr-290687
ABSTRACT
Mitochondrial adenosine triphosphate (ATP) synthase is the key enzyme of mitochondrial oxidative phosphorylation reaction. The down-regulation of the mitochondrial ATP synthase is a hallmark of most human carcinomas, which is the embodiment of the bioenergetic signature of cancer in the performance of the decreased oxidative phosphorylation and increased aerobic glycolysis. Combining with the bioenergetic signature of cancer, studies showed that mitochondrial ATP synthase and multidrug resistance and adverse prognosis of tumor were closely related. Its mechanisms are related to post-transcriptional regulation of the ATP synthase, the hypermethylation of the ATP synthase gene and the inhibitor peptide of the mitochondrial ATP synthase, called ATP synthase inhibitory factor 1 (IF1). In this review, we stress the biological characteristics of mitochondrial ATP synthase and the relationship between ATP synthase and multidrug resistance and prognosis of Malignant tumor, in order to find a new way for tumor therapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Fosforilación Oxidativa
/
Carcinoma
/
Regulación hacia Abajo
/
Adenosina Trifosfato
/
Óxido Nítrico Sintasa
/
ATPasas de Translocación de Protón Mitocondriales
/
Metabolismo Energético
/
Metabolismo
/
Mitocondrias
/
Neoplasias
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Biomedical Engineering
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS